RSS   Newsletter   Contact   Advertise with us
Post Online Media

Arena Pharma appoints EVP, chief business officer

Arena PharmaceuticalsArena Pharmaceuticals, a biopharmaceutical company, announced that Vincent Aurentz is joining its management team as executive vice president and chief business officer.

Mr. Aurentz joins Arena with over 27 years of experience in the pharmaceutical and biotech industry.

Article continues below

READ MORE Arena Pharma appoints Amit D. Munshi as president and CEO

Prior to Arena, he served as the Chief Business Officer of Epirus Biopharmaceuticals.

Prior to that, Mr. Aurentz served as President of HemoShear Therapeutics, where he oversaw the scientific and business development efforts including collaborations with global organizations such as Pfizer, Eli Lilly, Janssen R&D and Children's National Health System.

Before his time at HemoShear Therapeutics, Mr. Aurentz was Executive Vice President and a member of the Executive Management Board at Merck KGaA (Merck Serono) where he directed R&D programs, portfolio strategy and headed deal activity and venture investments.

Mr. Aurentz is a former Executive Vice President at Quintiles, and Co-founder and Managing Director of a venture capital and advisory business. He started his career at Andersen Consulting (now Accenture).


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy